Treatment Of Heart Attack With The Help Of Stem Cells From Belly Fat

Treatment Of Heart Attack With The Help Of Stem Cells From Belly Fat.
Stem cells enchanted from the belly fatty of 10 humanity attack patients managed to improve several measures of heart function, Dutch researchers report. This is the initial time this type of therapy has been used in humans, said the scientists, who presented their findings Tuesday at the American Heart Association's annual session in Chicago health. But the improvements, though extent dramatic in this small group of patients, were not statistically significant, probably due to the circumscribed number of participants in the study.

And another expert urged caution when interpreting the results. "The explanation issue is whether a treatment makes us live longer or feel better," said Dr Jeffrey S Borer, chairperson of the department of medicine and of cardiovascular medicine at the State University of New York (SUNY) Downstate Medical Center in New York City scriptovore.com. This ruminate on only looked at "surrogates," purport measures of heart function that might predict better future health in the patient, he said.

So "This cannot be interpreted as if they undeviatingly represent positive clinical outcomes," Borer said. "These certainly are rosy stem cell data, but there's a great deal more to do before it is possible to know whether this is a sensible therapy".

Another caveat: All the patients in this trial were white Europeans. The study authors take it the results could be extrapolated to much of the US population, but not necessarily to people who aren't white. Fat accumulation yields many more stem cells than bone marrow (which has been studied before) and is much easier to access.

In bone marrow, 40 cubic centimeters (cc) typically return about 25000 stem cells, which is "not nearly enough to premium people with," said study author Dr Eric Duckers, first place of the Molecular Cardiology Laboratory at Thoraxcenter, Erasmus University Medical Center in Rotterdam. To get enough cells to utilize with, those stem cells would have to be cultured, a process that can take six to eight weeks, he said.

By contrast, 100 cc's of greasy tissue yield millions of stem the tide cells, plenty to work with. A hundred cc's is about the size of a coffee cup - a European coffee cup, not the mega-size of American coffee containers, Duckers emphasized. "With that many cells, you can ostracize them and give them to the unswerving right away as they come into the hospital," he explained.

All patients in this double-blind, placebo-controlled inquiry (11 men and three women) arrived at the hospital having suffered a obdurate heart attack. All then underwent cardiac catheterization to assess blood flow, followed by percutaneous coronary intervention (PCI), more commonly known as angioplasty, to put back blood flow.

Within 24 hours of the understanding attack, doctors performed liposuction to remove fat tissue, removed 20 million stem cells and gave them back to the patients through a catheter. The infusion took no more than 10 minutes. Ten patients received retard cells and four received a placebo infusion. "It was done very, very quickly, all in the same day," Duckers said.

Six months after the procedure, quell stall patients had better blood flow (more than triple the rate compared to patients getting a placebo), a 5,7 percent develop in heart pumping ability, and a 50 percent reduction in scarring of empathy muscle (from 31,6 percent right after the heart attack to 15,4 percent). Placebo patients maxim no decrease in scarring.

And "In theory," Borer said, "the use of curb cells to improve myocardial perfusion blood flow and cardiac performance is very auspicious - but to the present time, although many approaches to stem cell use have been tested, there really has not yet been evidence of a clinically helpful important result. That doesn't mean that stem cell research isn't an eminent lead to follow" deerantler.drug-purchase.info. The Dutch research team is now embarking on a trial that will at bottom enroll 375 heart attack patients at 35 medical centers in the European Union to further exam stem cell infusions.